203 related articles for article (PubMed ID: 21420049)
1. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
Cardiology; 2010; 115(3):200-4. PubMed ID: 20160440
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
4. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
6. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
7. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
9. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
Lopes RD; Starr A; Pieper CF; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Mahaffey KW; Armstrong PW; Harrington RA; White HD; Wallentin L; Granger CB
Am J Med; 2010 Feb; 123(2):134-40. PubMed ID: 20103022
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of patients with atrial fibrillation aged over 80 years in daily clinical practice: influence of age and CHADS(2) score.
Lotze U; Liebetrau J; Malsch I; Frühwirt B; Rothhagen B; Kharatyan N; Neubauer K
Arch Gerontol Geriatr; 2010; 50(1):36-41. PubMed ID: 19233488
[TBL] [Abstract][Full Text] [Related]
12. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
[TBL] [Abstract][Full Text] [Related]
13. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
14. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Stenestrand U; Lindbäck J; Wallentin L;
Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
[TBL] [Abstract][Full Text] [Related]
17. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience.
Halbfass P; Janko S; Dorwarth U; Riess G; Antoni D; Hoffmann E
Europace; 2009 Jul; 11(7):957-60. PubMed ID: 19493910
[TBL] [Abstract][Full Text] [Related]
18. [Adequacy of anticoagulant prevention in patients with atrial fibrillation].
García-García J; Calleja-Puerta S; de la Vega-Cerezales V; Benavente-Fernández L; Rodríguez-Rodríguez S; Hernández-Lahoz C
Rev Neurol; 2005 Oct 1-15; 41(7):399-403. PubMed ID: 16193445
[TBL] [Abstract][Full Text] [Related]
19. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
